Aigen Investment Management, LP
Position in RLAY — Relay Therapeutics, Inc.
CIK 1741224
NEW YORK, NY
Position in RLAY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$219,646
+$78,123 QoQ
Shares Held
22,075
+31.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $12,762,383 across 22 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,452 | $3,701,631 | |
| 2 | INCY |
Incyte Corp
|
23,563 | $2,671,101 | |
| 3 | INSM |
INSMED Inc
|
16,847 | $1,796,227 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,073 | $1,086,350 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
2,390 | $585,000 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
24,477 | $356,629 | |
| 7 | JANX |
Janux Therapeutics, Inc.
|
22,841 | $350,837 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
5,218 | $314,958 |
All Filings in RLAY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $219,646 | 22,075 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | $141,523 | 16,828 | Shares | Sole | 2023-11-13 | |
| 2021-09-30 | $231,051 | 7,328 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||